Challenges and Enablers in Platform Trial Methodologies - Takeaways - MDSpire

Challenges and Enablers in Platform Trial Methodologies

  • By

  • Stuart McLennan

  • Alexandra Griessbach

  • Sharon Love

  • Christof Manuel Schönenberger

  • Alain Amstutz

  • Lucille Sebastian

  • Dominique Costagliola

  • Inge Christoffer Olsen

  • Corina Silvia Rueegg

  • Matthew R. Sydes

  • Matthias Briel

  • Benjamin Speich

  • April 2, 2026

  • 0 min

Share

  • 1

    Platform trials allow for simultaneous evaluation of multiple interventions, enhancing efficiency compared to traditional randomized clinical trials.

  • 2

    The initiation of platform trials doubled at the start of the COVID-19 pandemic, highlighting their growing importance in clinical research.

  • 3

    Challenges in platform trials include operational complexity, resource capacity prediction, funding acquisition, and engagement with pharmaceutical companies.

  • 4

    A survey was conducted to gather insights from platform trial teams on barriers and facilitators, aiming to improve clinical trial infrastructure.

  • 5

    The research team included experts in clinical research methods and bioethics, ensuring a comprehensive approach to understanding platform trials.

Original Source(s)

Related Content